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Schizophrenia and autism are thought to result from the interaction between a susceptibility genotype and environmental risk factors.
The offspring ofwomenwho experience infectionwhile pregnant have an increased risk for these disorders.Maternal immune activation
(MIA) in pregnant rodents produces offspring with abnormalities in behavior, histology, and gene expression that are reminiscent of
schizophrenia and autism, making MIA a useful model of the disorders. However, the mechanism by which MIA causes long-term
behavioral deficits in theoffspring is unknown.Herewe show that the cytokine interleukin-6 (IL-6) is critical formediating thebehavioral
and transcriptional changes in the offspring. A single maternal injection of IL-6 on day 12.5 of mouse pregnancy causes prepulse
inhibition (PPI) and latent inhibition (LI) deficits in the adult offspring. Moreover, coadministration of an anti-IL-6 antibody in the
poly(I:C) model of MIA prevents the PPI, LI, and exploratory and social deficits caused by poly(I:C) and normalizes the associated
changes in gene expression in thebrains of adult offspring. Finally,MIA in IL-6 knock-outmicedoesnot result in several of thebehavioral
changes seen in the offspring of wild-type mice after MIA. The identification of IL-6 as a key intermediary should aid in the molecular
dissection of the pathwayswherebyMIA alters fetal brain development, which can shed new light on the pathophysiologicalmechanisms
that predispose to schizophrenia and autism.
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Introduction
Birth in winter or spring months is an accepted risk factor for
schizophrenia, and the preponderance of evidence suggests that
the prevalence of influenza in winter months is responsible
(Tochigi et al., 2004). Over 25 studies have analyzed schizophre-
nia incidence after influenza epidemics, and the majority have
found an increased incidence among exposed offspring. More
recently, Brown and colleagues (Brown and Susser, 2002; Brown
et al., 2004; Brown, 2006) examined the medical records of
12,000 pregnant women and found that second-trimester re-
spiratory infection increases the risk for schizophrenia in the off-
spring threefold to sevenfold. Because of the high prevalence of
influenza infection, they estimate that 14–21% of schizophrenia
cases are caused by maternal infection. These findings are also
supported by an association between elevated cytokines or anti-
influenza antibodies in maternal serum and schizophrenia in the
offspring (Brown et al., 2004). Maternal infectionmay also play a
role in the pathogenesis of autism (Patterson, 2002). These links
are even more remarkable considering that the epidemiological
studies are unable to screen for susceptibility genotype. Because
of the strong genetic component in autism and schizophrenia, it
is likely that only genetically susceptible individuals who were
exposed to maternal infection would develop the disorder, sug-
gesting that the risk associated with maternal infection may be
considerably more than threefold to sevenfold in susceptible
individuals.
Several lines of evidence indicate that the maternal immune
response, rather than direct infection of the fetus, is responsible
for the increased incidence of schizophrenia and autism in the
offspring of mothers who suffer infections during pregnancy
(Patterson, 2005). First, human influenza infection is usually
confined to the respiratory tract. Moreover, in a mouse model,
influenza infection during pregnancy produces behavioral defi-
cits in the adult offspring (Shi et al., 2003), but we detected no
virus in the fetuses (Shi et al., 2005). Most importantly, injecting
either the double-stranded RNA poly(I:C) or bacterial lipopoly-
saccharide (LPS), which both induce strong innate immune re-
sponses in the absence of infection, into pregnant rodents pro-
duces behavioral and histological abnormalities in the adult
offspring similar to those seen in the offspring of infected moth-
ers (Shi et al., 2003; Zuckerman et al., 2003; Fortier et al., 2004a;
Zuckerman and Weiner, 2005; Meyer et al., 2006; Ozawa et al.,
2006). After maternal immune activation (MIA) by influenza
infection, LPS, or poly(I:C), cytokine levels are altered in the
maternal serum as well as the amniotic fluid, placenta, and fetal
brain (Fidel et al., 1994; Cai et al., 2000; Urakubo et al., 2001;
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Gayle et al., 2004; Paintlia et al., 2004; Gilmore et al., 2005; Ash-
down et al., 2006; Beloosesky et al., 2006;Meyer et al., 2006; Xu et
al., 2006). Because cytokines drive the innate immune response,
they are logical candidates for disruption of fetal brain
development.
We have examined several proinflammatory cytokines as po-
tential mediators of the effects of MIA on fetal brain develop-
ment. Using the behavior of adult offspring as the readout, we
first tested whether injection of single cytokines in the uninfected
mother can mimic the effects of maternal infection on the off-
spring. To then test the involvement of endogenous cytokines, we
asked whether anti-cytokine antibodies can block the effects of
maternal poly(I:C) injection on the offspring and whether MIA
affects the behavior of offspring of cytokine knock-out (KO)
mice. The data identify interleukin-6 (IL-6) as a key mediator of
the effects of MIA on fetal brain development.
Materials andMethods
Generation of animals
Female C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) were
obtained from our in-house breeding facility and were housed in venti-
lated cages under standard laboratory conditions.Miceweremated over-
night, and the presence of a vaginal plug marked that day as embryonic
day 0 (E0). Pregnant females were not disturbed, except for weekly cage
cleaning, until E12.5 when they were weighed and pseudo-randomly
assigned to one of seven groups. Each group initially contained at least
five pregnant females.
Cytokine injection
Mice were given intraperitoneal injections of either 5 g of carrier
protein-free recombinant mouse IL-6 or 5 g of carrier-free recombi-
nant mouse interferon  (IFN) (R & D Systems, Minneapolis, MN)
freshly dissolved in 200l of 0.9% saline. Control mice were given injec-
tions of 200l of vehicle. Injections in themicrogram range in adultmice
cause acute behavioral effects (Swiergiel et al., 1997); our pilot experi-
ments suggested thatmaternal doses in this range have a significant effect
on adult offspring.
Cytokine blocking
Four groups of mice were given intraperitoneal injections of 20 mg/kg
poly(I:C) (potassium salt; Sigma, St. Louis, MO) freshly dissolved in
saline, because previous experiments found this dose to bemost effective
with intraperitoneal delivery (Shi et al., 2003). The manufacturer sup-
plies poly(I:C) at 10%of the total weight of the salt, and dosage was based
on theweight of poly(I:C) itself. Someof themicewere given coinjections
of 100 g of cytokine-neutralizing antibody targeted against IL-6 (anti-
IL-6; rat IgG1), IFN (anti-IFN; rat IgG2a), or IL-1 (anti-IL-1; rat
IgG1) (R & D Systems), freshly dissolved in sterile saline. The total injec-
tion volume was 200 l. The half-life of rat IgG1 and IgG2a in pregnant
mice is similar to that of mouse IgG, with an -phase lasting24 h and
a -phase lasting200 h, with 2–3%maternofetal transmission (Mede-
san et al., 1998). The antibody dose was calculated to be approximately a
10-foldmolar excess of themaximal cytokine levels observed in response
to poly(I:C). Control mice were given injections of either 200l of saline
or 100 g of anti-IL-6 freshly dissolved in 200 l of saline.
IL-6 KO mice
IL-6 KOmice, strain B6.129S2-IL6tm1Kopf/J, backcrossed for 11 gener-
ations onto a C57 background, were obtained from The Jackson Labora-
tory and maintained in our facility by homozygous breeding. Mice were
mated and were given injections of 20 mg/kg poly(I:C) or saline, using
the procedures outlined above.
All pregnant mice were single housed after injection and returned to
the same cage rack. Mice were left undisturbed, except for weekly cage
cleaning, until the pups were weaned at 3 weeks of age. Offspring were
housed in same-sex groups of two to five animals.
Measurement of maternal cytokine levels
Pregnant females were given injections of saline, poly(I:C), poly(I:C)
plus anti-IL-6, or poly(I:C) plus anti-IFN, as above. Three hours after
injection, mice were killed with an overdose of sodium pentobarbital
(Nembutal), and blood was collected via cardiac puncture into Eppin-
dorf tubes and allowed to clot at room temperature for 1 h. Blood was
centrifuged at 8000 g for 10 min at 4°C, and the serum was aliquoted
and stored at80°C until use. ELISAs for IL-6, IFN, and IL-1 (R & D
Systems) were preformed according to the manufacturer’s instructions.
For immunoprecipitation of anti-cytokine antibodies, a biotinylated,
anti-rat antibody that was preabsorbed with mouse serum to prevent
binding tomouse antibodies (Vector Laboratories, Burlingame, CA) was
conjugated to streptavidin magnetic beads (NEB, Ipswich, MA) over-
night at 4°C. After washing the beads thoroughly with PBS,mouse serum
was diluted 1:20 in PBS and incubated with the beads for 4 h at room
temperature. The beads were removed magnetically, and the resulting
serum was used directly for ELISA.
Cytokine detection array kits were purchased from RayBioTech
(Norcross, GA), and the manufacturer’s instructions were followed.
Briefly, antibody-spotted membranes were treated with blocking solu-
tion, incubated overnight at 4°C with 50 l of mouse serum to be tested,
washed with wash buffer, and probed with biotinylated anti-cytokine
antibodies, and binding was detected using streptavidin–HRP
chemiluminescence.
Behavioral testing
Latent inhibition. The protocol was modeled after Zuckerman and
Weiner (2005). Each group of mice was randomly subdivided into two
groups, pre-exposed (PE) and not pre-exposed (NPE). Mice were placed
in a box (Coulborn Instruments, Allentown, PA)with a speakermounted
on the back wall and an infrared motion detector on the ceiling. PE mice
were presented with 40 tones (2000 Hz, 30 s duration) separated by 30
40 s to randomize the intertone interval. NPE mice were placed in the
same enclosure for an equivalent amount of time. Immediately after
pre-exposure, all mice were given three pairing trials of the 30 s tone
immediately followed by a 1 s, 0.3 mA footshock delivered through the
floor. Pairing trials were separated by 180 s. The next day, the mice were
returned to the same enclosure for 8 min to measure context freezing
(measured as described below). The following day, mice were again re-
turned to the enclosure and, after a 180 s acclimation period, were pre-
sented with an 8min tone presentation. Freezing during the tone presen-
tationwasmeasured by the sensors anddefined as a period of4 s during
which movement was not detected. Data are presented as percentage of
the time spent freezing during tone presentation, and latent inhibition
(LI) is defined as the difference in the amount of freezing in response to
the tone in PE mice compared with NPE mice.
Pilot experiments suggested that PE mice demonstrate a larger range
of time spent freezing than NPE mice, so the groups were split unevenly
[control-saline, 7 NPE mice and 20 PE mice; control-anti-IL-6, 7 NPE
mice and 15 PE mice; poly(I:C), 6 NPE mice and 13 PE mice; poly(IC)
plus anti-IL-6, 10 NPE mice and 29 PE mice; poly(IC) plus anti-IFN, 8
NPE mice and 12 PE mice; IL-6, 7 NPE mice and 10 PE mice; IFN, 3
NPEmice and 11 PEmice], resulting in small numbers ofNPE animals in
some groups. Initially, the NPE animals belonging to different groups
were treated as separate groups, but ANOVA revealed no significant
differences between the groups (F(6,41) 0.9241, p 0.05) (supplemen-
tal Fig. 1, available at www.jneurosci.org as supplemental material). Fear
conditioning was therefore similar in all groups, and the NPE groups
were merged for greater statistical power.
Prepulse inhibition. The prepulse inhibition (PPI) apparatus (San Di-
ego Instruments, San Diego, CA) consisted of a sound-insulated cham-
ber with a speaker mounted on the ceiling. The subject was restrained in
a Plexiglas cylinder inside the chamber, and a pliezo-electric sensor was
mounted beneath the restraining device to measure the startle response.
After a 5 min acclimation period, the subject was presented with six 120
dBpulses ofwhite noise. The subject was then presentedwith 14 blocks of
four different trial types in a pseudo-random order. Trial types included
P5P, in which a prepulse of 5 dB above background (67 dB) precedes the
startle stimulus by 100 ms; P15P, in which the prepulse is 15 dB above
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background; startle stimulus alone; and no stimulus. Trials were aver-
aged for each individual, and PPI was defined as PPI(X)  (startle
alone PXP)/(startle alone), where X 5 or 15.
Open field. Mice were placed in a 50  50 cm white Plexiglas box
brightly lit by fluorescent room lighting and six 60W incandescent bulbs
4–6 feet above the box. Activitywas recorded by a ceiling-mounted video
camera and analyzed using Ethovision software (Noldus, Leesburg, VA).
The software allows display of the paths taken by the mice, and it mea-
sures the total distance moved and the number of entries into the center
of the arena (central 17 cm square) in a 10 min session.
Social interaction. The testing apparatus consisted of a 60  40 cm
Plexiglas box divided into three chambers as described previously (Sank-
oorikal et al., 2006).Mice couldmove between chambers through a small
opening (6  6 cm) in the dividers. Plastic cylinders in each of the two
side chambers contained the probemice, and numerous 1 cmholes in the
cylinders enabled test and probe mice to contact each other. Mice to be
tested were placed in the center chamber, and an overhead camera re-
corded their movements. Mice were allowed 5 min to explore the box,
after which an unfamiliar, same-sex probe mouse from the same exper-
imental group was placed in one of two restraining cylinders. The Etho-
vision program measured time spent in each of the three chambers, and
social preference was defined as (% time spent in the social chamber)
(% time spent in the opposite chamber).
DNA microarray analysis
Micewere killed by cervical dislocation, and brains removed quickly. The
olfactory bulb was peeled back and removed, and a 2mm coronal section
of cortex was removed from the front of the brain with a clean razor
blade. This section was placed in a 1.5 ml tube and frozen in liquid
nitrogen. Total RNA was isolated using the Trizol reagent (Invitrogen,
Carlsbad, Ca). RNA quality was assessed using the Agilent (Palo Alto,
CA) Bioanalyzer. Reverse transcription, in vitro transcription, and frag-
mentation were performed according to the manufacturer’s recommen-
dations (Affymetrix, Sunnyvale, CA). Samples were hybridized onto
MOE430A mouse Affymetrix GeneChips that contained22,000 probe
sets using the Affymetrix hybridization station. To avoid microarray
batch variation, only microarrays from a single lot were used. Microar-
rays were considered for use only if the average 3:5 ratio for
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and actin did not
exceed 1:1.2. Segmentation of scannedmicroarray imageswas performed
byMicroarray Analysis Suite 5.0. Determination of expression levels and
scaling were performed using RobustMulti-array Average (Irizarry et al.,
2003a,b). For scale linearity, the data were log2 transformed, and differ-
ential expression was established using the average log2 ratio (ALR) be-
tween the studied cohorts (ALR 1 corresponds to a twofold increase
or decrease, ALR 0.585 represents a 50% change, and ALR 0.263
depicts a 20% expression alteration).
Statistical analysis
All data are shown as mean SEM. The statistical significance of differ-
ences between two groups was assessed using the Student’s t test, and
differences among multiple groups were assessed using one-way ANO-
VAs followed by Bonferroni post hoc tests.
Results
Effects of exogenous cytokines
Our pilot studies indicated that maternal administration of IL-6,
but not IL-1, tumor necrosis factor  (TNF), or IFN, causes
PPI deficits in the adult offspring. PPI is the inhibition of a startle
response when the startling stimulus is immediately preceded by
a smaller, nonstartling stimulus of the same modality and is a
measure of sensory-motor gating, attention, and distractibility.
PPI deficits are observed in several mental disorders, including
schizophrenia (Wynn et al., 2004) and autism (Perry et al., 2006).
Furthermore, PPI deficits in the offspring elicited by maternal
influenza infection respond to antipsychotic and psychomimetic
drugs (Shi et al., 2003), and the PPI deficit resulting from
poly(I:C) MIA is present in adult but not juvenile rats (Zucker-
man et al., 2003), mimicking the adult onset of schizophrenia.
The changes seen in this very relevant behavior prompted further
study of the effects of maternal IL-6 administration.
In a large follow-up study (for numbers of animals, see sup-
plemental Table 1, available at www.jneurosci.org as supplemen-
tal material), we confirmed that the offspring of pregnant mice
given injections of 5 g of IL-6 on E12.5 display lower PPI than
either control offspring ( p 0.01) or offspring of mothers given
injections of 5 g of IFN ( p 0.05) (Fig. 1a).
Both control offspring and offspring of mice given injections
of IFN display significant LI compared with NPE mice ( p 
0.001 and p 0.05, respectively). The offspring of IL-6-injected
mice lack significant LI ( p 0.05 vs NPE) (Fig. 1b). LI refers to
the inhibition of a conditioned response to a stimulus when an
individual has been repeatedly exposed to the stimulus before
pairing with the unconditioned response. LI is a measure of the
ability to ignore irrelevant stimuli, and its disruption is consid-
ered to be pertinent for the cognitive deficits in schizophrenia
(Weiner, 2003). LI is disrupted in schizophrenic subjects and in
amphetamine-treated humans and rats, restored to normal levels
in schizophrenics by neuroleptic drugs, and enhanced in normal
humans and rats by antipsychotic drugs (Weiner, 2003). As with
PPI, MIA in rats disrupts LI in adult, but not prepubertal, off-
spring (Zuckerman et al., 2003), and the disrupted LI of poly(I:
C)-exposed offspring responds to antipsychotic drugs (Zucker-
man and Weiner, 2005). Disruption of LI, enhanced
amphetamine-induced locomotion (Zuckerman et al., 2003;
Ozawa et al., 2006), and altered concentrations of dopamine and
its metabolites (Ozawa et al., 2006) caused by poly(I:C) MIA are
consistent with a subcortical dopamine dysfunction that is a cen-
tral feature of many theories of schizophrenia (Weiner, 2003).
Thus, a single injection of IL-6 on E12.5 causes deficits in two
relevant behaviors (LI and PPI) in the adult offspring.
Effects of anti-IL-6 on abnormal behaviors evoked by MIA
To test the role of endogenous IL-6 during MIA, we coadminis-
tered an IL-6-neutralizing antibody with poly(I:C) on E12.5. To
control for nonspecific effects of antibody administration, we
confirmed that a single maternal injection of anti-IL-6 antibody
alone does not cause behavioral changes in the offspring (PPI, LI,
and open field; data not shown). Furthermore, maternal coad-
ministration of poly(I:C) andneutralizing antibodies of the same,
or different, Ig subclass (IL-1/IgG1 or anti-IFN/IgG2a) pro-
duces offspring that behave similarly to the offspring of mice
given injections of poly(I:C) alone, indicating the lack of nonspe-
cific effects (see below). To ensure the efficacy of the antibodies,
Figure 1. The offspring of mice given injections of recombinant IL-6 exhibit abnormal be-
haviors.a, Offspring ofmice given injections of IL-6 but not IFN have a PPI deficit at a prepulse
intensity of 85 dB (F(2,79) 4.369; p 0.05). *p 0.05 versus control. b, PE offspring of
control mice show normal LI compared with NPE animals, as do PE offspring of IFN-injected
mothers. Offspring of IL-6-injected mothers, in contrast, do not demonstrate significant LI
(F(3,103) 10.22; p 0.0001). *p 0.05 versus NPE; **p 0.001 versus NPE.
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we measured cytokine levels in each treat-
ment group by ELISA and cytokine array
assay. We find that IL-6 and IL-1 are ele-
vated in mice given injections of poly(I:C)
and that anti-IL-6 binds 98% of the total
serum IL-6 induced by poly(I:C), without
significantly altering the levels of other cy-
tokines (supplemental Fig. 2, available at
www.jneurosci.org as supplemental
material).
We tested two separate, large sets of off-
spring for several relevant behaviors as
adults. Offspring of mice given injections
of poly(I:C) lack LI, as do the offspring of
mice given injections of poly(I:C) plus
anti-IFN-neutralizing antibody (Fig. 2a).
In contrast, mice given injections of
poly(I:C) plus anti-IL-6 antibody show
normal LI ( p 0.01 vs NPE). Offspring of
poly(I:C)-treated mothers also exhibit a
deficit in PPI ( p 0.001), whereas the PPI
of offspring of mice given injections of
poly(I:C) plus anti-IL-6 antibody is not
significantly different from controls but is
significantly higher than the PPI of off-
spring ofmice given injections of poly(I:C)
alone ( p  0.05) (Fig. 2b). Thus, a brief
neutralization of IL-6 during a critical pe-
riod of embryonic development prevents
two important behavioral deficits caused
by MIA.
Heightened anxiety and deficits in so-
cial interaction are hallmarks of schizo-
phrenia and autism. Reluctance to enter
the center portion of a well-lit open field is
usually taken as a measure of heightened
anxiety under mildly stressful conditions
(Shi et al., 2003). Compared with controls,
the offspring of poly(I:C)-injected mice
exhibit a deficit in open-field exploration,
as measured by entries into the center of
the field ( p  0.05) or by total distance
traversed ( p  0.01) (Fig. 2c,d). Neutral-
ization of IL-6 prevents these deficits ( p
0.05 and 0.001, respectively). In the social
interaction assay, control mice spend
more time in the social chamber of the ap-
paratus compared with the nonsocial
chamber, whereas offspring of poly(I:C)-injected mice do not
show a preference for the social chamber ( p  0.05) (Fig. 2f).
Once again, neutralization of IL-6 prevents this deficit ( p 
0.05).
Effects of MIA in IL-6 KO mice
We also used genetically altered mice to test the requirement
for IL-6 in mediating MIA. The adult offspring of pregnant
IL-6 KO mice given injections of poly(I:C) on E12.5 display
robust PPI, similar to that found in adult offspring of saline-
injected IL-6 KO mice (control, 73.0  5.9%; poly(I:C),
81.2  2.0%; p  0.15). Moreover, the groups are similarly
active in the open-field test (center entries: control, 12.7 1.3;
poly(I:C), 10.2  1.9; p  0.62; distance traveled: control,
3360  201.8 cm; poly(I:C), 3202  243.5 cm; p  0.30), and
both groups display a similar strong preference for the social
chamber in the three-chamber social interaction test (control,
43.5  4.6%; poly(I:C), 33.2  6.7%; p  0.22). In the LI
paradigm, NPE offspring of both control- and poly(I:C)-
injected females do not display any significant conditioning
behavior (freezing; data not shown), making LI testing impos-
sible in IL-6 KOmice. The abnormal conditioning behavior of
the IL-6 KO mice suggests that IL-6 is important in brain
development and/or function, as indicated by other behav-
ioral studies (Armario et al., 1998; Butterweck et al., 2003;
Braida et al., 2004). The key point in the present context is,
however, that maternal poly(I:C) treatment has no effect on
PPI, social interaction, or open-field behavior of the adult
offspring, further demonstrating the importance of IL-6 in
causing behavioral deficits in the offspring of MIA mice.
Figure2. Abnormal behavior inMIAoffspring is preventedbymaternal treatmentwith anti-IL-6 antibody.a, Offspringofmice
treated with poly(I:C) lack LI. Coinjection of anti-IL-6 with poly(I:C) restores significant LI, whereas coinjection of anti-IFN does
not (F(4,132) 7.566; p 0.0001). **p 0.001 versus NPE; *p 0.01 versus NPE. b, Compared with controls, the offspring of
mice treated with poly(I:C) show a PPI deficit at a prepulse level of 85 dB. Coinjection with anti-IL-6 prevents this deficit. The PPI
of offspring of mice given coinjections of poly(I:C) and anti-IFN or anti-IL-1 are not significantly different from control or
poly(I:C) (F(4,270)4.195;p0.005). *p0.001versus control;
#p0.05 versuspoly(I:C). c,d, In theopen-field test, offspring
of mice treated with poly(I:C) make fewer entries than controls into the center (c) and travel less total distance (d). Offspring of
mice given coinjections of anti-IL-6 enter the center as often as control mice [F(3,123) 3.703; p 0.05; *p 0.05 vs control;
#p 0.05 vs poly(I:C)] and move a similar total distance [F(3,123) 6.666; p 0.0005; *p 0.01 vs control;
#p 0.001 vs
poly(I:C)]. Offspring of mice given coinjections of poly(I:C) and anti-IFN are not significantly different from controls or
poly(I:C). e, Tracks recorded during the open-field session demonstrate increased thigmotaxis in offspring of poly(I:C)-
treated mice compared with offspring of mice given coinjections of an IL-6 antibody. f, In the social interaction test,
control mice show a strong preference for the social chamber [defined as (percentage of time in social chamber) 
(percentage of time in opposite chamber)], whereas the offspring of poly(I:C)-treated mice show no such preference.
Again, the deficit is corrected by maternal administration of IL-6 antibody (F(3,50) 4.244; p 0.01). *p 0.05 versus
control; #p 0.05 versus poly(I:C).
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Effect of anti-IL-6 on changes in gene expression evoked
by MIA
Another measure of how MIA affects fetal brain development is
the alteration in gene expression in the brains of the offspring
(Fatemi et al., 2005). Rather than focusing on the identification of
individual genes, we used the microarray analysis to assess the
overall changes to the transcriptome caused by IL-6 and MIA.
mRNA was extracted from frontal cortex, which roughly corre-
sponds to the human prefrontal cortex, an area that shows mo-
lecular, functional, and microanatomical alterations in human
cognitive disorders (Lewis and Levitt, 2002). Tissue from five
adult animals from control, poly(I:C), and poly(I:C) plus anti-
IL-6 groups was individually processed and hybridized. Using a
cutoff value of p 0.01, 61 significant changes in gene expression
are identified in the offspring of the poly(I:C)-treated mice com-
pared with the saline-treated control animals. Fifty-five of these
61 genes (90%) do not show a statistically significant expression
difference when comparing poly(I:C) plus anti-IL-6-treated ver-
sus saline-treated animals. Using a two-way (samples and genes)
unsupervised hierarchical clustering of the gene expression in-
tensities, the three experimental groups separate into distinct
clusters (Fig. 3). Remarkably, four of the five mice in the
poly(I:C) plus anti-IL-6 group cluster with the control group,
rather than with the poly(I:C) group. A detailed analysis of the
microarray results, including confirmation of changes by PCR
and a detailed discussion of the genes identified, will be the sub-
ject of a future publication. The point of the analysis presented
here is the demonstration that maternal anti-IL-6 treatment pre-
vents the gene expression, as well as behavioral, changes caused
by poly(I:C) MIA.
Discussion
Maternal infection is an environmental risk factor for both
schizophrenia and autism (Brown and Susser, 2002; Patterson,
2002). The lack of evidence for direct infection of the fetus (Shi et
al., 2005) (but see Aronsson et al., 2002), and the fact that multi-
ple pathogens cause similar results in humans [e.g., influenza
(Brown, 2006), herpes (Babulas et al., 2006), rubella (Chess,
1977)], indicates that MIA, in general, is detrimental to the de-
veloping brain. The data presented here confirms previous re-
ports (see Introduction) that MIA causes behavioral and gene-
expression changes in the offspring of pregnant mice. When IL-6
is eliminated from the maternal immune response using genetic
methods or with blocking antibodies, however, the behavioral
deficits associated with MIA are not present in the adult off-
spring. Antibodies to IL-1 or IFN did not prevent behavioral
deficits, suggesting that the anti-IL-6 effect is specific. Further-
more, maternal exposure to IL-6, in the absence of poly(I:C) or
infection, is sufficient to cause two key deficits in the adult off-
spring, PPI and LI disruption. Thus, IL-6 is central to the process
by which MIA causes long-term behavioral alterations in the
offspring.
We also show that blocking IL-6 eliminates virtually all of the
transcriptional changes caused byMIA. Themicroarray data pre-
sented here are essentially numerical data that estimate the extent
to which treatment with the anti-IL-6 antibody is able to normal-
ize changes in expression. Our sole aim in including the numer-
ical data here is to demonstrate that blocking IL-6 prevents
90% of the changes seen in offspring of poly(I:C)-injected fe-
males, showing that gene expression changes, as well as behav-
ioral changes, are normalized by eliminating IL-6 from the ma-
ternal immune response.
Poly(I:C) signals through Toll-like receptor 3 via a nuclear
factor B-dependent mechanism (Alexopoulou et al., 2001). Al-
though usually cited for its ability to induce interferons (Toth et
al., 1990; Katafuchi et al., 2003; Voss et al., 2006), poly(I:C) is also
a strong inducer of IL-1, IL-6, and TNF- (Fortier et al., 2004b;
Traynor et al., 2004; Gilmore et al., 2005). Our pilot data suggest-
ing that IL-1, TNF-, and IFN do not cause behavioral
changes in the offspring may be surprising, because these cyto-
kines induce IL-6 in vivo (Gadient and Otten, 1997). However,
high levels of maternal IL-6 are necessary for the behavioral
changeswe observe in the adult offspring, and itmay be that these
cytokines [as well as lower intraperitoneal doses of IL-6 or poly(I:
C)] do not produce levels of IL-6 sufficient to have an effect on
the fetus.
Although it is remarkable that a single intraperitoneal injec-
tion of IL-6 is capable of altering the fetal brain, leading to abnor-
mal adult behavior, the cytokine stimulation by poly(I:C) is also
quite transient. Poly(I:C)-treated mice display sickness behavior
(lethargy, hunched posture, hindlimb stiffness), beginning 30
min after injection and lasting 6 h (data not shown), and a
biphasic temperature response consisting of 4–8 h of hyperther-
mia followed by 12–24 h of hypothermia (Traynor et al., 2004;
Cunninghamet al., 2007).However, the effects of poly(I:C) treat-
ment are mild compared with experimental influenza infection,
in which sickness behavior and hypothermia last for several days
(Yang and Evans, 1961; Shi et al., 2003). Previous work with
pregnant rats demonstrated that three injections of IL-6 over 5 d
caused increased latency to find the platform in the Morris water
maze in the adult offspring (Samuelsson et al., 2006). The total
amount of IL-6 administered to the rats was similar to the total
amount administered in our study, although the rats received the
dose spread over 5 d. The offspring of the IL-6-injected rats also
exhibited pyknotic cells similar to those reported in the offspring
of rats given injections of poly(I:C) (Zuckerman et al., 2003). This
pathology is not, however, observed in the offspring of maternal
poly(I:C)-treated mice (Meyer et al., 2006) (and our data not
shown). Early postnatal administration of epidermal growth fac-
tor or leukemia inhibitory factor over several days also cause PPI
deficits, tested in adulthood (Futamura et al., 2003; Watanabe et
al., 2004), but in none of these previous studies were the roles of
endogenous cytokines examined.
Ideally, one would like to extend these cytokine-blocking ex-
periments to themodel ofmaternal infectionwith influenza virus
(Shi et al., 2003), because this model more closely recapitulates
the human data related to mental illness. However, when preg-
nant C57 females are infected with influenza virus and given an
anti-IL-6 injection, they becomemore severely ill thanmice given
saline injections and either die or suffer miscarriage (data not
shown). Similar results were obtained with influenza infection of
IL-6 KOmice (data not shown). A previous study on experimen-
tal influenza infection in nonpregnant IL-6 KO mice reported
changes in weight loss, body temperature, and anorexia but did
not report effects on survival (Kozak et al., 1997). That study also
only lasted for 5 d, and we do not see major differences until 6–7
d,whenwild-typemice begin to recover andKOmice donot. The
increased severity of infection in IL-6-compromised mice forced
us to use the poly(I:C), pathogen-free MIA model for the IL-6
blocking experiments.
The observation that elimination of IL-6 in the MIA model
almost completely abrogates abnormal behaviors and transcrip-
tome changes in the offspring suggests that searches for other
mediators of MIA should be directed upstream and downstream
of IL-6, rather than in other signaling pathways. IL-6 is a pleio-
tropic cytokine that signals through heterodimerization of gp130
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and IL-6 receptor (IL-6R) on the cell surface (Bauer et al., 2007).
However, most cells express gp130, and the soluble form of the
IL-6R that is present in blood allows trans signaling (McLoughlin
et al., 2005), which enables many cells to respond to IL-6. In
considering the location of IL-6 action in the MIA model, three
major sites of signaling seem likely: thematernal immune system,
thematernal/fetal interface (i.e., the placenta), and the fetal brain.
The most obvious possibility is that IL-6 acts directly on the
fetal brain. IL-6 is known to play a role in brain development,
learning, and memory and in the CNS response to disease and
injury (Bauer et al., 2007). IL-6 is central to inflammation-
inducedworkingmemory disruption (Sparkman et al., 2006) and
plays an important role in long-term potentiation in normal rats
(Balschun et al., 2004). During development, the STAT (signal
transducers and activators of transcription) pathway, through
which IL-6 signals, regulates the balance between neurogenesis
and gliogenesis (He et al., 2005) and IL-6 triggers brain endothe-
lial cells to divide andmigrate (Yao et al., 2006). After injury, IL-6
can assume very different roles, triggering either neuronal sur-
vival or neuronal degeneration, throughmechanisms that are not
well understood (Gadient and Otten, 1994; Wagner, 1996; Harry
et al., 2006). Regarding access to the fetus, radiolabeled IL-6 can
enter the rat fetus duringmid, but not late, gestation (Dahlgren et
al., 2006), which correlates with human data showing influenza
infection increases risk for schizophrenia only in the second tri-
mester (Brown, 2006). Elevated levels of cytokine protein and
mRNA (including IL-6) have been detected in embryonic serum
and brain afterMIA (Fidel et al., 1994; Cai et al., 2000;Urakubo et
al., 2001; Gayle et al., 2004; Paintlia et al., 2004; Gilmore et al.,
2005; Ashdown et al., 2006; Beloosesky et al., 2006; Meyer et al.,
2006; Xu et al., 2006). IL-6 can regulate brain-derived neurotro-
phic factor (BDNF) expression (Murphy et al., 2000), and a de-
crease in BDNF is found in embryos and placentas 24 h after
poly(I:C) administration (Gilmore et al., 2005). Thus, although
the pleiotropic nature of IL-6 makes it difficult to predict the
precise mechanism of action in the brain, many plausible path-
ways exist.
A second target of interest is the placenta, because IL-6 could
alter the transfer of nutrients, hormones, or other key molecules
to the fetus. IL-6 alters vascular permeability in the adult brain
after bacterial challenge (Paul et al., 2003), and expression of
genes responsible for the integrity of the placental barrier are
decreased after MIA (Beall et al., 2005). This could have signifi-
cant effects on transfer of potentially harmful proteins (i.e., anti-
bodies) into the fetal environment, or could allow maternal im-
mune cells to infiltrate the fetus.
IL-6 could also act on thematernal immune system, activating
lymphocyte migration and cytotoxicity and degrading maternal
tolerance of the fetus. Normal pregnancy is characterized by a
shift in basal cytokine production and other adjustments to pre-
vent rejection of the fetus (Sargent et al., 2006). Severe MIA
causes loss of pregnancy in rodents, and depletion of uterine
natural killer (uNK) cells prevents this loss, indicating that uNK
cells mediate the effect (Arad et al., 2005). IL-6 could also en-
hance production of maternal antibodies, which could cross-
Figure3. Unsupervised clusteringofmicroarraydata showanti-IL-6 treatment rescues tran-
scriptome changes in MIA offspring. Sixty-one genes show significant ( p 0.01) expression
differences between the adult offspring of poly(I:C)-treated and saline-injected mice. Two-
dimensional, unsupervised clustering of these genes (x-axis genes, y-axis samples) reveals
control (Sal; blue bars), poly(I:C) (pIC; red bars), and poly(I:C) plus anti-IL-6 (pIC	aIL6; purple
4
bars) animals cluster according to treatment, with only one pIC	aIL6 outlier. Significantly, the
pIC	aIL6 animals cluster with saline-injected controls, rather than with pIC offspring. Each
column represents expression values from a single animal. Genes are annotated by Affymetrix
probe set/Unigene identifiers. Color intensity represents themagnitude of the gene expression
change compared with the overall average intensity (green, decreased; red, increased; black,
unchanged).
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react with the fetal brain, as has been proposed to occur in autism
(Warren et al., 1990; Dalton et al., 2003; Vincent et al., 2003;
Singer et al., 2006; Zimmerman et al., 2007). Future research on
themechanism ofMIA effects on fetal brain development and on
potential therapeutic approaches can therefore productively fo-
cus on the effects of IL-6 on the maternal–fetal unit.
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